Data were extracted from the Global Burden of Disease 2017 study to dig deeper into the global, regional, and national cause-specific incidence of 5 rheumatic conditions. See what the researchers found. ...
New clinical trials have shed light on the management of gout since the American College of Rheumatology issued its 2012 guideline, prompting new recommendations for the use of urate-lowering therapy...
In a new population-based study, the authors sought to assess the risk of hypersensitivity reactions with allopurinol and febuxostat use among persons aged 65 years or older.
In a new population-based cohort study of nearly 300,000 adults with type 2 diabetes, researchers compared the incidence rates of gout among patients newly prescribed an SGLT2 inhibitor or a GLP-1 receptor...
Tuhina Neogi, MD, PhD, coprincipal investigator on the updated practice guideline for gout, discussed how the guideline will help rheumatologists manage gout in clinical practice at the 2019 ACR/ARP Annual...
Acute gout in frequently responsible ED visits, which are a major source of opioid prescriptions. In a recent study, researchers sought to assess the burden of opioid use among gout patients discharged from...
The authors of a new study measured opioid use and factors associated with it among more than 400 individuals with gout who were discharged from an emergency department.
The authors of a new study presented at the Annual European Congress of Rheumatology evaluated more than 6000 cases of gout and matched control cases to determine if occupational exposure to inorganic dust...
Multiple studies have demonstrated the ability of urate-lowering therapy to reduce or resolve tophi in patients with gout. Now, researchers sought to determine how quickly a certain drug could resolve the...
The FDA has called for the addition of a Boxed Warning alerting clinicians and patients of an increased risk of cardiovascular death with the use of a drug used for the treatment of gout.
